Neuro-ophthalmic complications of immune checkpoint inhibitor therapy: Current status and future directions
Since 2011, use of immune checkpoint inhibitors (ICI) in cancer immunotherapy dramatically expanded, both alone and in combination with either a different cancer treatment or with two different ICIs. With this increase in use have come a myriad of adverse effects from enhanced immune activation, inc...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2022-11-01
|
| Reeks: | Frontiers in Ophthalmology |
| Onderwerpen: | |
| Online toegang: | https://www.frontiersin.org/articles/10.3389/fopht.2022.1044904/full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|